Dr. Nasser Khan served as Chief Operating Officer of Acadia Healthcare from June 30, 2024 until his resignation effective November 3, 2025, after which he served as an executive advisor to the Company's Chief Executive Officer through December 31, 2025. He joined Acadia as Operations Group President for the company's comprehensive treatment center business line in September 2022.
Prior to joining Acadia, Dr. Khan served as Senior Vice President, Operations at Shields Health Solutions, a national provider of specialty pharmacy services to health systems and a subsidiary of Walgreens Boots Alliance, Inc. (NASDAQ: WBA), from July 2020 to August 2022. Before that, he served as Head of Program and Chief Medical Officer at Biograph Inc., a healthcare technology company, from May 2017 to June 2020. He also held a series of progressive operational leadership roles at DaVita, Inc. as Division Vice President of Hospital Services, Regional Operations Director, and Director of Strategy and Special Projects. Early in his career, Dr. Khan was an Engagement Manager at McKinsey & Company.
Dr. Khan holds a Doctor of Medicine (M.D.), a Master of Medical Science (M.M.S.) and a Bachelor of Arts in Human Biology from Brown University.